ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Arthritis"

  • Abstract Number: 984 • 2019 ACR/ARP Annual Meeting

    Important Role of CD11c+ Cells in Inflammatory Arthritis

    Antonia Puchner1, Elisabeth Simader 1, Victoria Saferding 2, Gerhard Kroenke 3, Rene Pfeifle 4, Daniel Aletaha 1, Josef Smolen 1 and Stephan Blueml 1, 1Medical University of Vienna, Vienna, Austria, 2Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 3Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Austria, 4University Hospital Erlangen, Erlangen, Germany

    Background/Purpose: Dendritic cells (DCs) are important antigen presenting cells (APCs) and therefore they play an important role in bridging the innate and the adaptive immune…
  • Abstract Number: 990 • 2019 ACR/ARP Annual Meeting

    Development of a Novel Anti TNF-Steroid Antibody Drug Conjugate That Shows Promising Efficacy at Doses That Avoid Steroid Side Effects in a Mouse Model of Rheumatoid Arthritis

    Wendy Waegell1, Christian Goess 2, Robert Stoffel 1, Michael McPherson 1, Adrian Hobson 1, Suzanne Mathieu 2, Lucy Phillips 1 and Shaughn Bryant 1, 1AbbVie, Worcester, 2Abbvie bioresearch Center, Worcester, MA

    Background/Purpose: TNF-inhibitors are a well established therapy for autoimmune diseases including rheumatoid arthritis, Crohn’s disease, psoriasis and ankylosing spondylitis but they have limited efficacy in…
  • Abstract Number: 998 • 2019 ACR/ARP Annual Meeting

    Stimulation of Splenic Neurovascular Bundle Protect Mice from Developing Collagen-induced Arthritis

    Thomas Simon1, Clara Panzolini 2, Julien Lavergne 2, Arun Srihar 3, Margriet Vervoordeldonk 3, nicolas Glaichenhaus 2 and Philippe Blancou 2, 1CNRS/IPMC, Valbonne, France, 2IPMC/CNRS, VALBONNE, France, 3Galvani Bioelectronics, Stevenage, United Kingdom

    Background/Purpose: Vagus nerve (VN) stimulation has shown the potential to improve the disease development in animal models of arthritis and in patients with RA. However,…
  • Abstract Number: 1001 • 2019 ACR/ARP Annual Meeting

    Oral Collagen Type V Supplementation Inhibits Cartilage Degeneration in Experimental Arthritis

    Lizandre Keren Silveira 1, José Eduardo Rodrigues 1, Silvana Atayde 1, Sergio Catanozi 1, Antonio dos Santos Filho 2, Vera Luiza Capelozzi 1, Ricardo Fuller 2, Ana Paula Velosa 2 and Walcy Teodoro1, 1Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Sao Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: It is known that collagen V (col V) can generate autoimmunity when exposed. In contrast, induction of tolerance with col V supplementation is able…
  • Abstract Number: 1185 • 2019 ACR/ARP Annual Meeting

    New Imaging Modality to Evaluate Arthritis in Lupus Based on Frequency-domain Optical Transmission

    Anca Askanase1, Fiamma Van Biema 2, Alessandro Marone 2, Youngwan Kim 2, Tommy Chen 2, Teja Kapoor 2, Laura Geraldino 2, Yevgeniya Gartshteyn 3 and Andreas Hielscher 2, 1Columbia University Medical Center, New York, NY, 2Columbia University School of Medicine, New York, NY, 3Columbia University School of Medicine, Glen Rock, NJ

    Background/Purpose: 95% of the people with SLE experience joint pain, stiffness and swelling at some time during their illness. It is currently difficult to both…
  • Abstract Number: 1186 • 2019 ACR/ARP Annual Meeting

    How Accurate Is Physical Joint Inflammation of the MTP-joints and What Can We Learn from Additional MRI on Forefoot Involvement in Early Arthritis?

    Yousra Dakkak1, Aleid Boer 1, Debbie Boeters 1, Annette van der Helm-van Mil 2 and Monique Reijnierse 1, 1Leiden University Medical Center, Leiden, Netherlands, 2LUMC, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: Magnetic resonance imaging (MRI) is more sensitive than physical examination in detecting inflammation. This has predominantly been studied in metacarpophalangeal-(MCP) and wrist-joints. Data on…
  • Abstract Number: 1263 • 2019 ACR/ARP Annual Meeting

    The Prevalence and Patterns of Celiac Disease Associated Arthropathy and Coexistence of Celiac Disease with Rheumatic Disorders in a Single Tertiary Medical Center

    Anita Moudgal1, Pooja Bhadbhade 1, Ammar Haikal 1 and Mehrdad Maz 1, 1The University of Kansas Medical Center, Kansas City, KS

    Background/Purpose: Celiac disease (CD) is a gluten-sensitive enteropathy that develops in genetically predisposed individuals. Arthropathy has been reported as an extra-intestinal manifestation of CD. The…
  • Abstract Number: 1771 • 2019 ACR/ARP Annual Meeting

    MyD88 S209R Enhances Inflammation in Mouse Models of Arthritis

    Sufia Bakshi1, Anders Lindstedt 2, Malika Waschmann 3, Wanxia Tsai 1, Robert Colbert 4 and Keith Sikora 1, 1National Institutes of Health, Bethesda, MD, 2NIH, Bethesda, MD, 3Oregon Health and Science University, Portland, OR, 4Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD

    Background/Purpose: MyD88 is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-kB. We previously reported a heterozygous de novo gain-of-function mutation in MYD88 (S222R)…
  • Abstract Number: 2062 • 2019 ACR/ARP Annual Meeting

    Arthritis, Physical Function, and Disability Among Older Mexican Americans over 20-Years of Follow-up

    Martin A Rodriguez1, Lin-Na Chou 1, Jaspreet K Sodhi 1, Kyriakos S Markides 1, Kenneth J Ottenbacher 1 and Soham Al Snih 1, 1The University of Texas Medical Branch, Galveston

    Background/Purpose: Hispanics are the fastest growing group of older adults in the US, with older Mexican Americans the largest segment of US Hispanics (65%), a…
  • Abstract Number: 2063 • 2019 ACR/ARP Annual Meeting

    Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)

    Martin A Rodriguez1, Jaspreet K Sodhi 1 and Soham Al Snih 1, 1The University of Texas Medical Branch, Galveston

    Background/Purpose: To examine the effect of arthritis on upper-lower extremity (UE-LE) functional limitations and disability over 6-years of follow-up among American older adults.Methods: Data are…
  • Abstract Number: 2119 • 2019 ACR/ARP Annual Meeting

    Impact of Day of Admission and Time to Diagnostic Arthrocentesis on Mortality and Other Outcomes in Septic Arthritis: A Nationwide Analysis

    Gustavo Contreras1, Ana B Arevalo 1, Shane Murray 1, Faris Haddadin 1 and Yiming Luo 1, 1Mount Sinai St. Luke's - West/ Icahn School of Medicine, New York, NY

    Background/Purpose: Multiple studies have been done assessing the “weekend effect” and outcomes for hospitalized patients 1,2,3,4, however, there is no data evaluating the outcome of…
  • Abstract Number: 136 • 2018 ACR/ARHP Annual Meeting

    Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Disease in Multiple Mouse Models of Autoimmunity

    Stacey Dillon1, Katherine Lewis1, Lawrence Evans2, Ryan Swanson2, Jing Yang3, Martin Wolfson4, Michelle Seaberg1, Kayla Susmilch5, Sherri Mudri1, Mark Rixon4, Stanford Peng6 and Kristine Swiderek7, 1Translational Sciences, Alpine Immune Sciences, Seattle, WA, 2Immunology, Alpine Immune Sciences, Seattle, WA, 3Clinical, R&D, Alpine Immune Sciences, SEATTLE, WA, 4Protein Therapeutics, Alpine Immune Sciences, Seattle, WA, 5Translational Sciences, Alpine Immune Sciences, SEATTLE, WA, 6Clinical, R&D, Alpine Immune Sciences, Seattle, WA, 7Research, Alpine Immune Sciences, SEATTLE, WA

    Background/Purpose: CD28 and Inducible T-cell Costimulator (ICOS) are two related costimulatory molecules within the immunoglobulin superfamily (IgSF) expressed on T cells and interacting with CD80/CD86…
  • Abstract Number: 1237 • 2018 ACR/ARHP Annual Meeting

    What Is the Value of Synovial Biopsies for the Diagnosis of Septic Arthritis?

    Bastien Ouvrard1,2, Géraldine Bart1, Christelle Darrieutort1, Aurélie Najm1 and Benoit Le Goff1, 1CHU Nantes, Nantes, France, 2INSERM UMR1238, nantes, France

    Background/Purpose: Synovial biopsies are increasingly performed for research purposes but also in clinical practice. The development of US guided procedure has made this procedure simpler.…
  • Abstract Number: 2972 • 2018 ACR/ARHP Annual Meeting

    Multicentric Reticulohistiocytosis (1980-2017): A Rare Disease, Commonly Associated with Malignancy and Autoimmunity

    Avneek Singh Sandhu1, Cynthia S. Crowson2, David Wetter3, Gavin McKenzie4 and Ashima Makol1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Dermatology, Mayo Clinic, Rochester, MN, 4Radiology, Mayo Clinic, Rochester, MN

    Background/Purpose: Multicentric reticulohistiocytosis (MRH) is a systemic disease characterized by papulo-nodular skin eruptions and progressive, deforming arthritis. We aimed to examine the clinical correlates and…
  • Abstract Number: 359 • 2018 ACR/ARHP Annual Meeting

    Characterization of Lymphoid Cells in Synovial Fluid from Cancer Patients with Immunotherapy-Induced Arthritis

    Sang Kim1, Jean Tayar1, Huifang Lu1, Jennifer Wang2, Don Gibbons3, Guillermo Garcia-Manero4, Patrick Hwu5, Adi Diab5 and Roza Nurieva6, 1General Internal Medicine (Rheumatology), MD Anderson Cancer Center, Houston, TX, 2Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, 3Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, 4Leukemia, MD Anderson Cancer Center, Houston, TX, 5Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, 6Immunology, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Checkpoint inhibitors (ICIs) are revolutionizing cancer treatment; however, ICI therapy is associated with immune-related adverse events (irAEs). irAEs can be life-threatening and/or severely impair…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology